 | ||
Clickfine pen needles are a brand of insulin pen needles distributed in the United States by Perrigo Diabetes Care and manufactured by Ypsomed AG. Clickfine pen needles are used to inject insulin for the treatment of diabetes.
Contents
Clickfine pen needles are made in Switzerland and feature a patented technology that enables users to ‘click-on’ the pen needle to attach it to the injection pen. The click-on feature generates an audible ‘click’ to confirm that the Clickfine pen needle is attached.
Description
Each Clickfine pen needle attaches to an insulin pen through a plastic needle hub. These hubs are specially designed to allow a click-on or screw-on attachment to the pen, depending on the user’s preference. Each pen needle features two protective caps as well as a layer of foil to protect the user and ensure sterility.
Clickfine pen needles are available in three sizes: 6 mm (1/4"), 31 gauge; 8mm (5/16"), 31 gauge; 12 mm (1/2"), 29 gauge.
Uses
Users select the appropriate sized Clickfine pen needle to inject insulin based on a number of factors. These include age, body type, injection technique, and insulin dose.
Each Clickfine pen needle is recommended for single use only.
Compatibility
Clickfine pen needles are designed for a universal fit with the following insulin pens: Apidra and Lantus SoloStar, Humalog KwikPen, Humulin Pen, Levemir and Novolog FlexPen, NovoPen, Victoza Pen. They also fit these other injection pens: Byetta Pen and Symlin Pen.
Market Share and Acceptance
While insulin pen needles account for more than 80 percent of insulin delivery product sales in Europe and Canada, the market share in the U.S. is less than 25 percent. This market share is growing, as evidenced by pen needles’ 40 percent sales growth in the U.S. in recent years.
An independent study found that the 64 percent of people with diabetes surveyed preferred click-on pen needles to traditional screw-on needles.